THE EFFECTS OF TAXATION ON INVESTMENT: NEW EVIDENCE FROM FIRM LEVEL PANEL DATA

1992 ◽  
Vol 45 (3) ◽  
pp. 243-251
Author(s):  
JASON G. CUMMINS ◽  
KEVIN A. HASSETT
Keyword(s):  
1998 ◽  
Vol 31 (4) ◽  
pp. 749 ◽  
Author(s):  
Susan E. Feinberg ◽  
Michael P. Keane ◽  
Mario F. Bognanno

2013 ◽  
Vol 52 (2) ◽  
pp. 97-126 ◽  
Author(s):  
Zara Liaqat

Using a sample of 321 textile and clothing companies for the years 1992 to 2010, this paper analyses the effect of quota phase-outs on firm-level efficiency in Pakistan following the end of the Multi-Fibre Arrangement (MFA). It highlights sectoral heterogeneity within the manufacturing industry as a result of MFA expiration. The empirical methodology uses the structural techniques proposed by Olley and Pakes (1996), and Levinsohn and Petrin (2003) in order to take care of endogeneity in the estimation of production functions. The results differ for the two industries: MFA expiration lead to an increase in the average productivity of textile producing firms but a significant reduction in the mean productivity of clothing producers. We offer a number of explanations for this outcome, such as a change in the input and product mix, entry by non-exporters in the clothing sector, and sectoral differences in quality ladders. A number of crucial policy lessons can be drawn from the findings of this study. JEL Classification:F13; F14; D24; C14; O19 Keywords: Multi-Fibre Arrangement, Trade Liberalisation, Productivity, Firm Heterogeneity, Simultaneity and Production Functions, Endogeneity of Protection


2011 ◽  
Vol 51 (1) ◽  
pp. 88-104 ◽  
Author(s):  
M. Kabir Hassan ◽  
Benito Sanchez ◽  
Jung-Suk Yu

World Economy ◽  
2021 ◽  
Author(s):  
Benoît Mahy ◽  
François Rycx ◽  
Guillaume Vermeylen ◽  
Mélanie Volral
Keyword(s):  

Author(s):  
Shilpi Tyagi ◽  
DK Nauriyal

This paper analyzes the R&D and exports profile of Indian drug and pharmaceutical industry during the period 2000–2014. The present paper examines how R&D expenditure and patent impact export performance of the Indian drug and pharmaceutical firms. The study period from 2000 to 2014 has been characterized by a rapid growth in industry’s innovative activity, as part of the strategic shift, induced by the Patents (Amendment) Act, 2005. Using the real financial data for the top 91 publicly listed Indian domestic pharmaceutical companies, the study provides new evidence on firm-level export performance of the Indian drugs and pharmaceutical industry. Generalized Method of Movements estimator developed by Blundell and Bond is applied. The empirical findings of the study reveal that increased R&D intensity, higher patent count and firm’s size are important determinants of firm-level export performance.


Author(s):  
Domenico Siniscalco ◽  
Bernardo Bortolotti ◽  
Marcella Fantini
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document